Total Live Articles: 409

Urticaria

NICE CKS Urticaria. Last revised: Jan 2025.

Urticaria

Urticaria, also known as hives, weals or nettle rash, is a superficial swelling of the skin that causes a red, raised and intensely itchy rash.

This updated UKMLA guide to urticaria (acute and chronic) is based on NICE CKS, which covers types, causes, symptoms, diagnosis, and management.

Definition and Types

Urticaria refers to the superficial swelling of the skin (epidermis and mucous membrane)

  • Acute urticaria: last <6 weeks
  • Chronic urticaria: last ≥6 weeks

Angioedema is a deeper form of urticaria:

  • Caused by transient swelling of deeper dermal, subcutaneous and submucosa tissues
  • Often affecting the face (lips, tongue, eyelid), genitalia, hands or feet

Urticaria and angioedema can co-exist (~40% of cases), but either can occur separately

Causes and Risk Factors

Urticaria is driven by mast cells releasing histamine and other inflammatory mediators (e.g. leukotrienes, prostaglandins), causing

  • Pruritus
  • ↑ Vascular permeability
  • Oedema

Acute Urticaria (<6 Weeks)

Acute urticaria may occur spontaneously, or in response to a trigger:

  • Acute viral infection (viral-induced urticaria is common in children)
  • Allergic reaction to
    • Certain foods (e.g. milk, eggs, peanuts, tree nuts, shellfish)
    • Insect bites and stings
    • Contact allergens (e.g. latex)
    • Certain drugs (e.g. penicillins, aspirin, NSAIDs, vaccinations)

Chronic Urticaria (≥6 weeks)

There are 2 main types of chronic urticaria:

Chronic spontaneous urticaria Urticaria occurs with no identifiable external cause (but symptoms may be aggravated by heat, stress, drugs and infection)

This includes autoimmune urticaria (urticaria occurs in the presence of IgG to IgE receptors +/- associated with other autoimmune conditions)

Chronic inducible urticaria Urticaria occurs in response to a physical stimulus

It can be further classified according to the physical stimulus

  • Water → aquagenic urticaria
  • Active or passive warming (e.g. from exercise, emotion) → cholinergic urticaria
  • Cold → cold urticaria
  • Heat → heat urticaria
  • Shear force on the skin (e.g. scratching) → symptomatic dermatographism
  • Sustained pressure (e.g. tight clothing, prolonged sitting or lying) → delayed pressure urticaria
  • UV exposure → solar urticaria
  • Vibration → vibratory angioedema

Chronic urticaria that is painful and persistent (lesions remain for >24 hours) should raise suspicion of vasculitic urticaria. There may be systemic symptoms, such as fever, malaise, and arthralgia.

Clinical Features and Diagnosis

Urticaria is primarily a clinical diagnosis

3 typical features of urticaria:

  • Pruritus and/or burning sensation
  • Central swelling of variable size (red / white), usually with a surrounding erythema / flare
  • Fleeting nature – skin returns to normal within 1-24 hours

Investigations for Underlying Cause

Consider the following investigations to identify underlying causes / treatable associated conditions / trigger factors:

  • LFT
  • TFT (+ve thyroid antibodies + chronic urticaria suggests autoimmune urticaria)
  • ESR / CRP (↑ inflammatory markers suggest underlying systemic condition)
  • FBC (↑ eosinophil count may suggest drug-induced reaction or parasitic infection)
  • H. pylori testing (if GI symptoms are present) (see the Helicobacter Pylori Infection article for more information)
  • Allergy testing
  • Elimination of suspected food or drugs
  • Skin biopsy (for atypical presentation or suspected urticarial vasculitis)
  • Urinalysis (for suspected vasculitis)
  • Physical challenge (for chronic inducible urticaria)

Red flags Features (Anaphylaxis)

The most important differential diagnosis to exclude is anaphylaxis, as urticaria may occur as part of the presentation.

Assess urgently for ABC problems:

  • Airway – angioedema, stridor, drooling
  • Breathing – widespread wheezing, hypoxia, cyanosis
  • Circulation – hypotension, tachycardia, syncope/collapse, reduced GCS

Anaphylaxis is a potentially life-threatening medical emergency, see the Anaphylaxis article for more information.

Management

Advise patient:

  • If there is an identifiable trigger → avoid it if possible
  • Mild urticaria with an identifiable and avoidable cause/trigger is likely to be self-limiting without treatment

Symptomatic (pharmacological) management:

  • 1st line: non-sedating antihistamine (e.g. cetirizine, fexofenadine, loratadine) for up to 6 weeks
  • For severe symptoms, give a short-course (up to 7 days) of oral corticosteroid (e.g. prednisolone) in addition to the antihistamine
    • Consider referral if a steroid is needed in <16 y/o
    • Do not repeat the course of oral steroids unless advised by a specialist

Ongoing antihistamine therapy (if symptoms improved):

  • If the symptoms are short-lived and frequent recurrence is unlikely → prescribe to be taken as required or prophylactically
  • If the symptoms are likely to be persistent or recurrent (e.g. chronic spontaneous urticaria) → prescribe daily antihistamines for 3-6 months, then review

If there is inadequate response to 1st line non-sedating antihistamine, consider the following options:

  • Increase the dose to up to 4x the licensed dose (off-label) in adults (seek a specialist before doing so in children)
  • Switch to an alternative non-sedating antihistamine
  • Add an LTRA (e.g. montelukast, zafirlukast) in addition to the antihistamine
  • Topical antipruritic treatment (e.g. calamine lotion, topical menthol aqueous cream)
  • Add a sedating antihistamine (e.g. chlorphenamine) at night if the itch is interfering with sleep
  • Refer to a dermatologist or immunologist

References

Related Articles

Anaphylaxis

Atopic Dermatitis (Eczema)

Allergic Rhinitis

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.